Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,793.00 INR | +1.83% |
|
-2.53% | -18.90% |
08/07 | Concord Biotech Limited, Q4 2025 Earnings Call, May 30, 2025 | |
02/07 | Stellon Biotech Inc announced that it has received $0.0015 million in funding from Concord Biotech Limited | CI |
Main competitors
Consensus (Composite) | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Ecart obj. / dr | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
₹1,937 | +10.01% | 5 | |||||||
A$202.23 | +25.19% | 17 | |||||||
$728.3 | +35.34% | 24 | |||||||
₩13,18,038.46 | +28.09% | 26 | |||||||
€212.29 | +24.95% | 17 | |||||||
$171.15 | +31.52% | 31 | |||||||
HK$72.54 | -3.85% | 28 | |||||||
₩5,65,000 | +35.49% | 2 | |||||||
- | - | - | - | - | |||||
$75.41 | +12.09% | 23 | |||||||
$47.59 | +59.17% | 22 | |||||||
$95.52 | +66.38% | 28 | |||||||
- | - | CN¥53.1 | -11.22% | 1 | |||||
SEK 347.25 | +21.42% | 12 | |||||||
$60 | +37.93% | 19 | |||||||
€15.96 | +52.12% | 13 | |||||||
HK$18.52 | -17.35% | 10 | |||||||
CN¥29.73 | +52.95% | 6 | |||||||
- | CN¥6.2 | -9.36% | 1 | ||||||
Average | 1,04,839.51 | +25.05% | 16 | ||||||
Weighted average by Cap. | 2,13,278.92 | +26.97% | 19 |
- Stock Market
- Equities
- CONCORDBIO Stock
- Sector Concord Biotech Limited
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition